Arrow Capital Pty Ltd purchased a new position in Blue Owl Capital Inc. (NYSE:OWL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 130,000 shares of the company's stock, valued at approximately $3,024,000. Blue Owl Capital comprises 2.8% of Arrow Capital Pty Ltd's holdings, making the stock its 16th largest holding.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Rothschild Investment LLC increased its position in shares of Blue Owl Capital by 316.1% during the fourth quarter. Rothschild Investment LLC now owns 33,955 shares of the company's stock valued at $790,000 after acquiring an additional 25,795 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Blue Owl Capital by 17.9% in the third quarter. JPMorgan Chase & Co. now owns 9,030,397 shares of the company's stock worth $174,829,000 after purchasing an additional 1,372,865 shares during the last quarter. Arizona State Retirement System lifted its holdings in shares of Blue Owl Capital by 14.7% during the fourth quarter. Arizona State Retirement System now owns 154,708 shares of the company's stock valued at $3,599,000 after purchasing an additional 19,810 shares in the last quarter. Princeton Global Asset Management LLC bought a new position in shares of Blue Owl Capital during the fourth quarter valued at $1,773,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in Blue Owl Capital by 3.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,447,057 shares of the company's stock worth $80,179,000 after buying an additional 106,485 shares in the last quarter. Institutional investors own 35.85% of the company's stock.
Blue Owl Capital Trading Up 2.0 %
OWL traded up $0.34 on Friday, reaching $17.44. The stock had a trading volume of 6,634,079 shares, compared to its average volume of 6,612,198. The business's 50-day moving average price is $19.95 and its two-hundred day moving average price is $22.21. Blue Owl Capital Inc. has a 12-month low of $14.55 and a 12-month high of $26.73. The company has a market cap of $26.81 billion, a P/E ratio of 102.56, a price-to-earnings-growth ratio of 1.23 and a beta of 1.20.
Blue Owl Capital (NYSE:OWL - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.21 earnings per share for the quarter, hitting analysts' consensus estimates of $0.21. Blue Owl Capital had a net margin of 4.77% and a return on equity of 20.82%. As a group, analysts predict that Blue Owl Capital Inc. will post 0.92 earnings per share for the current year.
Blue Owl Capital Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Wednesday, February 19th were issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 4.13%. The ex-dividend date was Wednesday, February 19th. Blue Owl Capital's dividend payout ratio is currently 423.53%.
Wall Street Analysts Forecast Growth
OWL has been the topic of a number of research reports. JMP Securities dropped their price target on Blue Owl Capital from $32.00 to $28.00 and set a "market outperform" rating on the stock in a research note on Tuesday, April 8th. Evercore ISI increased their price objective on shares of Blue Owl Capital from $25.00 to $26.00 and gave the stock an "outperform" rating in a research note on Friday, January 17th. Oppenheimer set a $24.00 target price on shares of Blue Owl Capital and gave the company an "outperform" rating in a research report on Wednesday. Piper Sandler reduced their target price on shares of Blue Owl Capital from $27.00 to $21.00 and set an "overweight" rating for the company in a report on Tuesday, April 8th. Finally, Wells Fargo & Company dropped their price target on shares of Blue Owl Capital from $22.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 8th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Blue Owl Capital has an average rating of "Moderate Buy" and a consensus target price of $23.79.
Get Our Latest Report on Blue Owl Capital
About Blue Owl Capital
(
Free Report)
Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.
Read More

Before you consider Blue Owl Capital, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blue Owl Capital wasn't on the list.
While Blue Owl Capital currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.